12-6016231-C-A

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000552.5(VWF):​c.5313G>T​(p.Gly1771Gly) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0022 in 1,614,156 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0086 ( 12 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 29 hom. )

Consequence

VWF
NM_000552.5 splice_region, synonymous

Scores

2
Splicing: ADA: 0.00002680
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 0.604
Variant links:
Genes affected
VWF (HGNC:12726): (von Willebrand factor) This gene encodes a glycoprotein involved in hemostasis. The encoded preproprotein is proteolytically processed following assembly into large multimeric complexes. These complexes function in the adhesion of platelets to sites of vascular injury and the transport of various proteins in the blood. Mutations in this gene result in von Willebrand disease, an inherited bleeding disorder. An unprocessed pseudogene has been found on chromosome 22. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 12-6016231-C-A is Benign according to our data. Variant chr12-6016231-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 196663.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-6016231-C-A is described in Lovd as [Likely_benign]. Variant chr12-6016231-C-A is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.604 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00861 (1311/152264) while in subpopulation AFR AF = 0.0279 (1158/41554). AF 95% confidence interval is 0.0265. There are 12 homozygotes in GnomAd4. There are 625 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 1311 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VWFNM_000552.5 linkc.5313G>T p.Gly1771Gly splice_region_variant, synonymous_variant Exon 31 of 52 ENST00000261405.10 NP_000543.3 P04275-1
VWFXM_047429501.1 linkc.5313G>T p.Gly1771Gly splice_region_variant, synonymous_variant Exon 31 of 52 XP_047285457.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VWFENST00000261405.10 linkc.5313G>T p.Gly1771Gly splice_region_variant, synonymous_variant Exon 31 of 52 1 NM_000552.5 ENSP00000261405.5 P04275-1
VWFENST00000538635.5 linkn.421-22297G>T intron_variant Intron 5 of 5 4

Frequencies

GnomAD3 genomes
AF:
0.00862
AC:
1311
AN:
152146
Hom.:
12
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0279
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00375
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00416
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000617
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00317
AC:
798
AN:
251480
AF XY:
0.00273
show subpopulations
Gnomad AFR exome
AF:
0.0295
Gnomad AMR exome
AF:
0.00179
Gnomad ASJ exome
AF:
0.00427
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000747
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00154
AC:
2247
AN:
1461892
Hom.:
29
Cov.:
32
AF XY:
0.00152
AC XY:
1104
AN XY:
727246
show subpopulations
Gnomad4 AFR exome
AF:
0.0307
AC:
1028
AN:
33480
Gnomad4 AMR exome
AF:
0.00199
AC:
89
AN:
44724
Gnomad4 ASJ exome
AF:
0.00375
AC:
98
AN:
26136
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39700
Gnomad4 SAS exome
AF:
0.00357
AC:
308
AN:
86256
Gnomad4 FIN exome
AF:
0.00
AC:
0
AN:
53420
Gnomad4 NFE exome
AF:
0.000424
AC:
472
AN:
1112012
Gnomad4 Remaining exome
AF:
0.00346
AC:
209
AN:
60396
Heterozygous variant carriers
0
153
305
458
610
763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00861
AC:
1311
AN:
152264
Hom.:
12
Cov.:
32
AF XY:
0.00840
AC XY:
625
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.0279
AC:
0.0278674
AN:
0.0278674
Gnomad4 AMR
AF:
0.00418
AC:
0.00418465
AN:
0.00418465
Gnomad4 ASJ
AF:
0.00375
AC:
0.00374856
AN:
0.00374856
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.00416
AC:
0.00415973
AN:
0.00415973
Gnomad4 FIN
AF:
0.00
AC:
0
AN:
0
Gnomad4 NFE
AF:
0.000617
AC:
0.000617429
AN:
0.000617429
Gnomad4 OTH
AF:
0.00664
AC:
0.00663507
AN:
0.00663507
Heterozygous variant carriers
0
63
126
189
252
315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00795
Hom.:
11
Bravo
AF:
0.0100
EpiCase
AF:
0.00131
EpiControl
AF:
0.000889

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 29, 2023
Quest Diagnostics Nichols Institute San Juan Capistrano
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Nov 06, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:3
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 26, 2015
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

von Willebrand disease type 2 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 3 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

von Willebrand disease type 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
5.4
DANN
Benign
0.59
Mutation Taster
=53/47
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000027
dbscSNV1_RF
Benign
0.036
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2229448; hg19: chr12-6125397; COSMIC: COSV99075169; COSMIC: COSV99075169; API